Skip to main content
Search form
Search
Subscribe to newsletter +
European Association of Hospital Pharmacists
Menu
Main menu
Home
About Us
Who we are
Board
Staff
Students
Transparency
Contact Information
Call for Expressions of Interest
Members
Associate membership
News
Press Releases
EAHP Newsletters
EAHP in the news
Multimedia Gallery
Events
Calendar
Academy
Synergy Masterclass
EAHP BOOST
Congresses
General Assemblies
Accreditations
EAHP Synergy Certification Courses
Open Learning
Get Involved
Sponsors and partners
HP Practice
EAHP COVID-19 Resource Centre
European Statements of Hospital Pharmacy
What hospital pharmacists do
EAHP-ESCP Oath to Society
FIP global statements
National legislation on hospital pharmacy
Good Practice Initiatives
Common training framework
Environmental Sustainability
European Council for Pharmacy Education Accreditation
Investigation of the hospital pharmacy profession in Europe
Hospital Pharmacy Day
SIGs
Controlled Substances Management
Special Interest Group on Investigation of medication errors and efficiency in oncology
Automated Medication Management
Working Towards Eliminating Avoidable Harm
Hazardous Medicinal Products
Hospital Pharmacist’s Preparedness for in-vivo gene therapy medicinal products
Investigation of Medication Errors in Intensive Care Units
Use of Prefilled Syringes in Intensive Care Units and Operating Theaters
Policy
Resources
Consultations
Position Papers
Get involved and keep up to date
Access to Medicines
Ageing society
Infectious Diseases and AMR
ATMPs
Bar coding medicines to the single unit
Biosimilar medicines
Clinical trials
Digital Health
EMA - EAHP collaboration
European List of Emergency Medicines
Falsified Medicines
Hazardous Medicinal Products
Hospital Pharmacy Specialisation
Medical device regulation
Medicines shortages
Patient safety
Pharmaceuticals in the environment
Pharmacy preparations and compounding
Procurement
Public spending austerity
SmPC
Vaccination
Workforce
Statements
GPIs
Publications
2019 EP Election Manifesto
General information
EAHP Annual report
European Journals of Hospital Pharmacy
EAHP Surveys of HP practice
EAHP History Book
Practical Pharmaceutics
Congress presentation webcasts
2024 European Parliament Election Manifesto
Member Center
You are here
Home
Clinical Pharmacy
CP-167
RENAL DONOR OR RECRUDESCENCE AS ORIGIN OF MALARIA INFECTION
CP-165
IMPACT ON HOSPITAL READMISSION OF MEDICATION RECONCILIATION IN POST EMERGENCY GERIATRIC UNIT : A PILOT STUDY
CP-164
AN AUDIT OF SELF-ADMINISTRATION OF MEDICINES IN CARDIOVASCULAR WARDS AND PATIENT'S PREFERENCE FOR MEDICINES ADMINISTRATION WHILE AN INPATIENT
CP-163
ONCO-HEMATOLOGICAL OUTPATIENTS TREATED WITH ORAL ANTINEOPLASTIC AGENTS: PHARMACIST INTERVENTIONS
CP-161
A CLINICAL AND COST ANALYSIS OF MEDICATION RECONCILIATION BY PHARMACISTS AT THE POINT OF HOSPITAL DISCHARGE
CP-160
CARBAPENEM DE-ESCALATION THERAPY FOR INTRA-ABDOMINAL INFECTION.
CP-155
PREVALENCE AND EFFECTIVINESS OF ANTIRETROVIRAL TREATMENT COMBINATIONS USED IN HIV PATIENTS NOT COLLECTED IN GUIDELINES
CP-153
LIRAGLUTIDE ADEQUACY AND EFFECTIVENESS IN REAL PRACTICE TYPE 2 DIABETES THERAPY
CP-151
ASSESSMENT OF AN EXPERIMENTAL CALL CENTER DEDICATED TO DRUG INFORMATION FOR OUTPATIENTS
CP-148
ACUTE CONFUSIONAL STATE: CASE REPORT
CP-147
A MEDICATION THERAPY MANAGEMENT PROGRAM FOR CHRONIC PATIENT : ABOUT PATIENT SATISFACTION IN CARDIOLOGY
CP-145
QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS: EXPERIENCE IN A UNIVERSITY HOSPITAL OUTPATIENT PHARMACY
CP-144
FIRSTLINE TRIPLET OR DOUBLET CHEMOTHERAPY FOR HER2 NEGATIVE ADVANCED OESOPHAGOGASTRIC CANCER: AN ANALYSIS FROM A COMMUNITY PRACTICE REGISTRY
CP-140
ANALYSIS OF DISTRIBUTION AND ACCEPTABILITY OF PHARMACEUTICAL INTERVENTIONS AFTER IMPLANTATION OF THE ELECTRONIC ASSISTED PRESCRIPTION
CP-138
SPIRONOLACTONE IN PAEDIATRICS. TOXICITY UPDATE.
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
Follow Us